vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.

CareCloud, Inc. is the larger business by last-quarter revenue ($34.4M vs $23.1M, roughly 1.5× SMITH MIDLAND CORP). On growth, SMITH MIDLAND CORP posted the faster year-over-year revenue change (24.7% vs 21.9%). Over the past eight quarters, SMITH MIDLAND CORP's revenue compounded faster (17.4% CAGR vs 15.1%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.

CCLD vs SMID — Head-to-Head

Bigger by revenue
CCLD
CCLD
1.5× larger
CCLD
$34.4M
$23.1M
SMID
Growing faster (revenue YoY)
SMID
SMID
+2.8% gap
SMID
24.7%
21.9%
CCLD
Faster 2-yr revenue CAGR
SMID
SMID
Annualised
SMID
17.4%
15.1%
CCLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCLD
CCLD
SMID
SMID
Revenue
$34.4M
$23.1M
Net Profit
$2.1M
Gross Margin
57.5%
Operating Margin
9.1%
37.8%
Net Margin
9.2%
Revenue YoY
21.9%
24.7%
Net Profit YoY
52.5%
EPS (diluted)
$0.06
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
SMID
SMID
Q4 25
$34.4M
$23.1M
Q3 25
$31.1M
$21.5M
Q2 25
$27.4M
$26.2M
Q1 25
$27.6M
$22.7M
Q4 24
$28.2M
$18.5M
Q3 24
$28.5M
$23.6M
Q2 24
$28.1M
$19.6M
Q1 24
$26.0M
$16.8M
Net Profit
CCLD
CCLD
SMID
SMID
Q4 25
$2.1M
Q3 25
$3.1M
$2.9M
Q2 25
$2.9M
$4.2M
Q1 25
$1.9M
$3.3M
Q4 24
$1.4M
Q3 24
$3.1M
$3.1M
Q2 24
$1.7M
$2.0M
Q1 24
$-241.0K
$1.1M
Gross Margin
CCLD
CCLD
SMID
SMID
Q4 25
57.5%
Q3 25
26.8%
Q2 25
0.0%
Q1 25
30.7%
Q4 24
51.4%
Q3 24
27.9%
Q2 24
0.0%
Q1 24
23.3%
Operating Margin
CCLD
CCLD
SMID
SMID
Q4 25
9.1%
37.8%
Q3 25
10.3%
18.0%
Q2 25
10.9%
0.0%
Q1 25
7.3%
19.3%
Q4 24
12.2%
24.5%
Q3 24
11.4%
16.3%
Q2 24
8.1%
0.0%
Q1 24
0.5%
9.0%
Net Margin
CCLD
CCLD
SMID
SMID
Q4 25
9.2%
Q3 25
9.8%
13.4%
Q2 25
10.6%
15.9%
Q1 25
7.0%
14.7%
Q4 24
7.5%
Q3 24
10.9%
13.4%
Q2 24
6.0%
10.1%
Q1 24
-0.9%
6.8%
EPS (diluted)
CCLD
CCLD
SMID
SMID
Q4 25
$0.06
$0.41
Q3 25
$0.04
$0.54
Q2 25
$0.04
$0.79
Q1 25
$-0.04
$0.62
Q4 24
$0.00
$0.28
Q3 24
$-0.04
$0.59
Q2 24
$-0.14
$0.37
Q1 24
$-0.10
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
SMID
SMID
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$54.3M
Total Assets
$87.6M
$87.7M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Total Debt
CCLD
CCLD
SMID
SMID
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCLD
CCLD
SMID
SMID
Q4 25
$59.5M
$54.3M
Q3 25
$57.8M
$52.1M
Q2 25
$56.1M
$49.2M
Q1 25
$54.2M
$45.1M
Q4 24
$49.8M
$41.7M
Q3 24
$46.5M
$40.3M
Q2 24
$43.2M
$37.2M
Q1 24
$41.4M
$35.3M
Total Assets
CCLD
CCLD
SMID
SMID
Q4 25
$87.6M
$87.7M
Q3 25
$90.6M
$85.4M
Q2 25
$75.2M
$81.2K
Q1 25
$73.6M
$74.7M
Q4 24
$71.6M
$68.0M
Q3 24
$70.7M
$66.6M
Q2 24
$74.0M
$64.0M
Q1 24
$76.9M
$64.9M
Debt / Equity
CCLD
CCLD
SMID
SMID
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
SMID
SMID
Operating Cash FlowLast quarter
$8.7M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
SMID
SMID
Q4 25
$8.7M
Q3 25
$7.4M
$11.7M
Q2 25
$7.4M
Q1 25
$5.1M
$2.2M
Q4 24
$5.2M
$-645.0K
Q3 24
$7.1M
$3.9M
Q2 24
$4.3M
$2.7M
Q1 24
$4.1M
$-777.0K
Free Cash Flow
CCLD
CCLD
SMID
SMID
Q4 25
$6.6M
Q3 25
$6.5M
$6.3M
Q2 25
$6.2M
Q1 25
$4.5M
$1.6M
Q4 24
$4.3M
$-1.3M
Q3 24
$6.7M
$1.8M
Q2 24
$4.2M
$998.0K
Q1 24
$3.8M
$-2.6M
FCF Margin
CCLD
CCLD
SMID
SMID
Q4 25
19.0%
Q3 25
20.9%
29.5%
Q2 25
22.8%
Q1 25
16.2%
7.1%
Q4 24
15.2%
-7.0%
Q3 24
23.6%
7.8%
Q2 24
14.8%
5.1%
Q1 24
14.5%
-15.3%
Capex Intensity
CCLD
CCLD
SMID
SMID
Q4 25
6.2%
Q3 25
2.8%
25.1%
Q2 25
4.2%
Q1 25
2.3%
2.6%
Q4 24
3.3%
3.6%
Q3 24
1.2%
8.6%
Q2 24
0.5%
8.7%
Q1 24
1.1%
10.7%
Cash Conversion
CCLD
CCLD
SMID
SMID
Q4 25
Q3 25
2.41×
4.07×
Q2 25
2.55×
Q1 25
2.62×
0.67×
Q4 24
-0.46×
Q3 24
2.26×
1.23×
Q2 24
2.56×
1.37×
Q1 24
-0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

SMID
SMID

Product Sales$13.8M60%
Service Revenue$9.3M40%

Related Comparisons